Mirum Pharmaceuticals, Inc. ($MIRM)
Filing Information
| Accession Number | 0001197350-26-000007 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 10, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
9,786
Total Value
$532,467.58
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CHIEF FINANCIAL OFFICER | Common Stock | โ | Jun 8, 2026 | Sale | 2,258 | $92.84 | $209,632.72 | 47,530 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Common Stock | โ | Jun 8, 2026 | Sale | 1,175 | $93.95 | $110,391.25 | 46,355 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Common Stock | โ | Jun 8, 2026 | Sale | 1,567 | $95.12 | $149,053.04 | 44,788 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Common Stock | โ | Jun 9, 2026 | Exercise/Conversion | 2,393 | $26.49 | $63,390.57 | 47,181 | Direct | โ | View Details | |
CHIEF FINANCIAL OFFICER | Employee Stock Option (right to buy) | Derivative | Jun 9, 2026 | Exercise/Conversion | 2,393 | $0.00 | $0.00 | 26,653 | Direct | โ | View Details |